Novolog Pharm Valuation
| NVLG Stock | 154.00 1.70 1.12% |
At this time, the firm appears to be overvalued. Novolog Pharm Up secures a last-minute Real Value of 127.85 per share. The latest price of the firm is 154.0. Our model forecasts the value of Novolog Pharm Up from analyzing the firm fundamentals such as Current Valuation of 1.45 B, return on equity of 0.11, and Profit Margin of 0.03 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Novolog Pharm's price fluctuation is very steady at this time. Calculation of the real value of Novolog Pharm Up is based on 3 months time horizon. Increasing Novolog Pharm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Novolog Pharm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Novolog Stock. However, Novolog Pharm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 154.0 | Real 127.85 | Hype 154.0 |
The real value of Novolog Stock, also known as its intrinsic value, is the underlying worth of Novolog Pharm Up Company, which is reflected in its stock price. It is based on Novolog Pharm's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Novolog Pharm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Novolog Pharm Up 1966 helps investors to forecast how Novolog stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Novolog Pharm more accurately as focusing exclusively on Novolog Pharm's fundamentals will not take into account other important factors: Novolog Pharm Total Value Analysis
Novolog Pharm Up 1966 is now estimated to have takeover price of 1.45 B with market capitalization of 1.09 B, debt of 916 K, and cash on hands of 107.97 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Novolog Pharm fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
| 1.45 B | 1.09 B | 916 K | 107.97 M |
Novolog Pharm Investor Information
About 42.0% of the company outstanding shares are owned by corporate insiders. The book value of Novolog Pharm was now reported as 0.86. The company last dividend was issued on the 24th of November 2022. Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange. To find out more about Novolog Pharm Up 1966 contact Rafi Friedman at 972 8 660 4400 or learn more at https://www.novolog.co.il.Novolog Pharm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Novolog Pharm has an asset utilization ratio of 54.85 percent. This suggests that the Company is making 0.55 for each dollar of assets. An increasing asset utilization means that Novolog Pharm Up 1966 is more efficient with each dollar of assets it utilizes for everyday operations.Novolog Pharm Ownership Allocation
Novolog Pharm Up maintains a total of 508.7 Million outstanding shares. Novolog Pharm Up 1966 holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Novolog Pharm Profitability Analysis
The company reported the revenue of 1.26 B. Net Income was 42.32 M with profit before overhead, payroll, taxes, and interest of 154.67 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Novolog Pharm's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Novolog Pharm and how it compares across the competition.
About Novolog Pharm Valuation
The stock valuation mechanism determines the current worth of Novolog Pharm Up 1966 on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Novolog Pharm Up 1966. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Novolog Pharm Up based exclusively on its fundamental and basic technical indicators. By analyzing Novolog Pharm's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Novolog Pharm's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Novolog Pharm. We calculate exposure to Novolog Pharm's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novolog Pharm's related companies.Novolog Ltd operates as a health logistics company in Israel. Novolog Ltd operates as a subsidiary of Pharm-Up Ltd. Novolog Ltd operates under Medical Care classification in Israel and is traded on Tel Aviv Stock Exchange.
8 Steps to conduct Novolog Pharm's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Novolog Pharm's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Novolog Pharm's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Novolog Pharm's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Novolog Pharm's revenue streams: Identify Novolog Pharm's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Novolog Pharm's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Novolog Pharm's growth potential: Evaluate Novolog Pharm's management, business model, and growth potential.
- Determine Novolog Pharm's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Novolog Pharm's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Novolog Stock analysis
When running Novolog Pharm's price analysis, check to measure Novolog Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novolog Pharm is operating at the current time. Most of Novolog Pharm's value examination focuses on studying past and present price action to predict the probability of Novolog Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novolog Pharm's price. Additionally, you may evaluate how the addition of Novolog Pharm to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |